Statin Primary Prevention Trial in HIV Halted for Efficacy ...Middle East

Medscape - News
Interim data from the REPRIEVE study showed that a daily statin cut the risk for cardiovascular events by 35% in adults with HIV at low to moderate CV risk. Medscape Medical News

Hence then, the article about statin primary prevention trial in hiv halted for efficacy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Statin Primary Prevention Trial in HIV Halted for Efficacy )

Apple Storegoogle play

Last updated :

Also on site :



Latest News